RFP Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
RFP Financial Group's XPH Position: Q3 2026 in Review
RFP Financial Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 4,722 shares worth $307K. The stake represents 0.15% of the portfolio and ranks #56 among its holdings.
117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- RFP Financial Group held 4,722 shares of State Street SPDR S&P Pharmaceuticals ETF worth $307K as of Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF was a new RFP Financial Group position in Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up 0.15% of RFP Financial Group's portfolio in Q3 2026, its #56 holding.
- 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on RFP Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.